BioPharm America 2014 EBD Group MassBio Image Map
Share:
Email this page Share this on LinkedIn Share this on Twitter

BioPharm America™ 2015 Press Releases

News for BioPharm America™ 2015 will be available soon.

October 2, 2014Record number of licensing opportunities presented at BioPharm America™ 2014 International Life Science Partnering Event in Boston The seventh annual BioPharm America international life science partnering conference wrapped up last week, September 22–24, at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The event was attended by close to 900 high-level delegates representing 511 companies from 38 countries who engaged in 2,343 one-to-one partnering meetings with 787 lice...  more ►

September 22, 2014FierceBiotech's 2014 "Fierce 15" Announced Today at BioPharm America™ 2014International Life Science Partnering Event in Boston
The seventh annual BioPharm America international life science partnering conference kicked off today in Boston with the live announcement of the biotech's most daring characters in biopharma, the "Fierce 15," by John Carroll, Editor-in-Chief of FierceBiotech. "It's always a lot of fun to look over a new group of Fierce 15 companies," said John Carroll, Editor-in-Chief, of ...  more ►

September 8, 2014BioPharm America™ 2014 leads off with Fierce 15 Announcement and Keynote Address featuring Chief Scientific Officer from Sanofi The seventh annual BioPharm America international life science partnering conference will kick off in a less than two weeks, September 22–24, at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The highly reputable life science partnering event will draw biotech and pharma executives from around the world to identify and enter into strategic r...  more ►

August 19, 2014Renewed investor appetite in biotech innovation means strong attendance expected at BioPharm America™ 2014 The seventh annual BioPharm America international life science partnering conference will be held September 22–24 at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The event is a big draw for pharma and investors who want to access innovative new potential therapies and cures brought by international biotech companies. "Today is a great time...  more ►

May 20, 2014Collaborative models and IPO window are hot topics at BioPharm America™ 2014 program The seventh annual BioPharm America international life science partnering conference will be held September 22–24 at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The event brings together industry thought leaders and high level executives in the biopharma dealmaking arena to collaborate on and discuss relevant trends and topics. Several i...  more ►

April 15, 2014BioPharm America™ 2014 returns to Boston's Copley Place and a celebration of the FierceBiotech Fierce 15 The seventh annual BioPharm America international life science partnering conference will be held at Boston Marriott Copley Place in the center of Boston's historic Back Bay. Produced by EBD Group in collaboration with the Massachusetts Biotechnology Council (MassBio), the September 22–24 event will bring the global life science industry to Boston to facilitate strategic ...  more ►



partnering360:Insight Latest headlines from partnering360:Insight

January 22, 2015 Life sciences democratize research and investing Non-accredited investors are beginning to have the opportunity to invest in biotech, thanks to some innovative new financing mechanisms and the growing democratization of healthcare, according to panelists at the Biotech Showcase™ 2015 financing session. more ►

January 16, 2015 Are old financing models enough? Last year saw more than USD 400 billion returned to investors through IPO exits and a bevy of new venture funds created, but this doesn’t signal a return to business as usual. Instead biotech financing in the future must continue to look to innovative strategies and must address reimbursement questions ever earlier in the race to attract funds, according to panelists at a Biotech Showcase™ 2015 lunch plenary. more ►

January 16, 2015 Regenerative medicine creating tangible value Regenerative medicine is beginning to add real value to healthcare not just by treating disease, but by curing disease. Most people—even those in the industry—don’t realize that more than 60 regenerative products have been approved, said Edward Lanphier. Some 500 companies are operating in this space globally, with 375 ongoing clinical trials. Of those, 340 are in Phase I or Phase II. Therefore, a great many products can be expected to be commercialized in the next few years. more ►

January 16, 2015 Perceptions of value and success There’s no single definition of value in the life sciences. Big pharma, investment bankers and venture capitalists each have different goals that affect their perception of value and guide their investment decisions. Panelists at a luncheon plenary session at Biotech Showcase™ 2015 made that point patently evident. more ►

January 16, 2015 The new immuno-oncology revolution Immuno-oncology is new again, fueled by research that has many scientists thinking a cure for cancer may be possible within their lifetimes. After the cancer vaccine misses of seven years ago, investors’ interests are once again piqued. The challenge is identifying exactly where in this fast-moving, complicated space to invest, according to Stephen Dunn, President and Senior Managing Partner, LifeTech Capital, speaking at Biotech Showcase™ 2015. more ►



Arrow Up


 
 
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2015 EBD Group, Inc.
Privacy Policy
Terms of Use
BioPharm America 2014 EBD Group MassBio Image Map